Skin conditions (dermatitis, eczema, psoriasis) decisions — 2022

The Veteran withdrew his appeals, and the Board dismissed the appeal due to the withdrawal.

The Board denied the Veteran's claims for service connection for skin cancer and chloracne, as well as his claim for an initial disability rating for diabetes mellitus. The Board also found that there was no evidence of a pending or unadjudicated claim for earlier effective dates for service connection of peripheral neuropathy and diabetes mellitus prior to the August 26, 2013 VA Form 21-4138 and December 2013 VA Form 21-526. The Board also remanded several issues for further development.

The Board has remanded the Veteran's claims for service connection due to an improper notice of disagreement form, and a statement of the case must be issued.

The Veteran's erectile dysfunction is granted as service connected, and he is granted TDIU on an extraschedular basis prior to June 25, 2007 due to his service-connected disabilities.

The Veteran's bilateral pes planus has been rated at 30 percent, but the Board found no evidence of pronounced acquired flatfoot or marked pronation to warrant a higher rating.,Prior to June 5, 2018, the Veteran's left Achilles tendonitis was rated at 10 percent. From that date forward, it has been rated at 20 percent.

The Board has remanded the case due to a failure to substantially comply with a previous remand, requiring another VA examination and medical opinion.

The appeal for hepatitis C (claimed as a liver condition) is dismissed. The case is remanded for an evaluation of tinea versicolor.

The Veteran's claims for service connection have been reopened, and the Board has determined that there is new and material evidence to reopen the claim of service connection for psoriasis. The lung disability and hepatitis B residuals issues are remanded due to insufficient medical opinions.

The Board has decided to remand the Veteran's claim for eczema as it requires a VA examination to determine if his current eczema is related to service, specifically use of prescribed acne medication (Accutane).

The Board has decided to remand the cases for further development and an addendum opinion regarding service connection for psoriasis and psoriatic arthritis.

The Veteran's claim for service connection for a bilateral foot disability has been remanded.,The Veteran's claim for an increased rating for tinea pedis was denied as the evidence did not meet the criteria for higher ratings.

The Veteran's appeals for increased disability ratings and effective dates have been dismissed as he has withdrawn his appeal.

The Veteran's appeal is remanded for obtaining additional private treatment records and for VA examinations to assess the impact of his service-connected disabilities on his employability.

The Veteran's appeals have been dismissed as he has withdrawn his appeal for all issues.

The Board has granted service connection for a skin condition, other than folliculitis barbae, as the Veteran's in-service rash and itching persisted after service.

The Board denied service connection for various conditions, including bilateral eye disability, headaches, gastroesophageal reflux disease (GERD), peripheral neuropathy of the upper and lower extremities, and chloracne. The decision also noted that an effective date earlier than March 24, 2017, for tinnitus was denied.

The Veteran's skin disorder (other than chloracne), bilateral sensorineural hearing loss, and vision impairment were not incurred or aggravated during service.,There is no evidence of a current disability for any of the conditions in question.

The Veteran's appeal has been dismissed due to his death. The claims for service connection and disability rating have not been decided.

The Veteran's bilateral hip arthritis and headaches have been granted service connection. The Veteran's chronic fatigue syndrome, lower extremity neurological disability (rhegulopathy), and atopic dermatitis were not granted service connection.

The Board has remanded the case due to inadequate analysis regarding systemic therapy for the Veteran's tinea pedis, requiring a new examination.